|
Is There Such a Thing as a Safe(r) Cigarette?
Tobacco Regulation and the FDA
A one-day event
Friday, Oct. 23, from 9 a.m. to noon
670 Albany Street (First-floor auditorium)
Boston, Massachusetts 02118
Boston University Medical Campus
A continental breakfast will be available from 8:15 a.m
*The event is free and open to the public
Directions to campus
2009 William J. Bicknell Lecturer
 Gregory Connolly, DMD, MPH, Professor of the Practice of Public Health at the Harvard School of Public Health
Connolly teaches and conducts research at Harvard School of Public Health on tobacco and health issues. He has published more than 100 scientific articles on tobacco product design, marketing and tobacco control interventions. He is the former director of Massachusetts Department of Public Health’s Tobacco Control Program and over the ten years he directed the program cigarette consumption fell 50 percent in Massachusetts, three times the U.S. average. He was the second American to be awarded the Surgeon General’s Medallion by Dr. C. Everett Koop for his leadership in passing the federal Comprehensive Smokeless Tobacco Health Education Act. He is recognized as an international expert on smoking and health and is credited with ending the U.S. use of trade threats to compel foreign nations to import U.S. cigarettes. He has testified before Congress on more than a dozen occasions and appears regularly on U.S. national news networks. Connolly is a graduate of Holy Cross College, Tufts Dental School, and Harvard School of Public Health.
Panelists:
 Patrick Basham has taught tobacco regulation and other health policy courses at Johns Hopkins University. He is founding director of the Democracy Institute, a politically independent think tank based in London and Washington DC. Basham previously served as a senior fellow at the Cato Institute, where he is currently an adjunct scholar. Prior to joining Cato, he served as founding director of the Social Affairs Center at the Fraser Institute, where he led the Institute's tobacco regulation research. He has written, lectured, and commentated extensively about regulation of the tobacco, food, and gambling industries. Basham has presented his research before respective domestic and foreign government commissions and committees, most recently at the House of Commons in London. Basham is coauthor of Hidden in Plain Sight: Why Tobacco Display Bans Fail, and is coauthor of the UK bestseller, Diet Nation: Exposing the Obesity Crusade. He wrote his Cambridge University doctorate on American politics. His articles have appeared in the British Medical Journal, The New York Times, Washington Post, Forbes, Sunday Telegraph, and The Independent.
 Cheryl Healton, DrPH, MPA, is founding president and chief executive officer of the American Legacy Foundation, non-profit whose mission is to build a world where young people reject tobacco and anyone can quit. Under her leadership, the organization has undertaken numerous public education campaigns, conducted research projects, and provided technical assistance and a broad program of grant making. She is recipient of the Secretary of HHS Award for Innovation in Public, the Social Justice Award from the State of Hawaii, and the American Lung Association’s Life and Breath Award in 2003. Most recently, Healton was named a Donald A. Berreth Lecturer by the National Public Health Information Coalition and is the recipient of the Troy R. Westmeyer Distinguished Alumnus/Alumna Award from New York University in 2008. She holds a doctorate from Columbia University's School of Public Health and a master's degree in Public Administration at New York University for Health Policy and Planning. She joined the American Legacy Foundation from Columbia University's Joseph L. Mailman School of Public Health in New York, where she served as Chair of the Division of Socio-medical Sciences and Associate Dean for Program Development.
 Michael Siegel, MD, MPH, is a physician whose primary research interest is in the area of tobacco control, focusing on secondhand smoke health effects, exposure, and policies, cigarette advertising and marketing practices and their effects on youths, and evaluation of tobacco control policies and their impact on youth and adult smoking behavior. His primary teaching is in the areas of mass communication, marketing, and public health advocacy. He is co-author of a book “Marketing Public Health: Strategies to Promote Social Change,” which grew out of his teaching experience at the School. He has been active in promoting smoke-free bar and restaurant policies throughout the country and has served as an expert witness in several major tobacco litigation cases. Siegel completed his residency in preventive medicine at the UC Berkeley School of Public Health and trained in epidemiology for two years at the Centers for Disease Control and Prevention in Atlanta before coming to Boston.
Siegel's tobacco blog
|
|
What does the Food and Drug Administration’s new power to regulate tobacco mean for smokers, for the public’s health, and for the future of the tobacco industry?
These and other questions surrounding the FDA’s still developing tobacco regulation program will be discussed and debated at the 2009 William J. Bicknell Lectureship in Public Health to be held at Boston University School of Public Health on Friday, October. 23, 2009.
The Friday morning session will feature an address by Bicknell Lecturer Gregory Connolly, DMD, MPH, Professor of the Practice of Public Health at the Harvard School of Public Health. Connolly’s lecture will be followed by a discussion by a distinguished panel of experts and audience question and answer session.
The event is named in honor of William J. Bicknell, chair emeritus and professor of international health at Boston University School of Public Health and professor of sociomedical sciences and community medicine at Boston University School of Medicine.
|
|
Boston University School of Public Health 
